KKR & Co. Inc. (NYSE: KKR) disclosed Friday that it has decided to sell The Bountiful Company to Nestle for $5.75 billion. KKR has earlier bought a majority interest in The Bountiful Company from The Carlyle Group in 2017. After the investment of KKR, The Bountiful Company has revolutionized into a top, fast growth, pure-play nutrition platform through substantial financing in talent, brand building, R&D, eCommerce, and production competencies.

As per the contract, Nestlé has agreed to purchase The Bountiful Company’s vitamin and supplement brands, Nature’s Bounty, Puritan’s Pride, Solgar, and Osteo Bi-Flex. These brands will be consolidated into Nestlé Health Science (NHSc) to establish a global leader in vitamins, minerals, and dietary supplements.

This selling agreement has identified the change of The Bountiful Company over the past 3+ years, as well as the shared value and abilities of the enterprises. The Bountiful Company is striving to fulfill the health and wellness needs of the customers. The firm has disclosed that the deal is anticipated to execute in the second half of 2021. The deal will be executed after the fulfillment of certain necessary conditions as well as after acquiring the necessary authorization.

Furthermore, Carlyle Partners V and Carlyle Europe Partners III funds maintained a minority stake in the firm and are involved in the sale along with KKR. The Head of Carlyle stated that it is delighted to see the business proceed with Nestlé.